| __timestamp | Dr. Reddy's Laboratories Limited | Dynavax Technologies Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 38783000000 | 17763000 |
| Thursday, January 1, 2015 | 42585000000 | 22180000 |
| Friday, January 1, 2016 | 45702000000 | 37257000 |
| Sunday, January 1, 2017 | 46372000000 | 27367000 |
| Monday, January 1, 2018 | 46910000000 | 64770000 |
| Tuesday, January 1, 2019 | 48890000000 | 74986000 |
| Wednesday, January 1, 2020 | 50129000000 | 79256000 |
| Friday, January 1, 2021 | 54559000000 | 100156000 |
| Saturday, January 1, 2022 | 62081000000 | 131408000 |
| Sunday, January 1, 2023 | 105931000000 | 152946000 |
| Monday, January 1, 2024 | 77201000000 |
In pursuit of knowledge
In the ever-evolving pharmaceutical landscape, understanding operational efficiency is crucial. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of Dr. Reddy's Laboratories Limited and Dynavax Technologies Corporation from 2014 to 2023.
Dr. Reddy's Laboratories has shown a consistent increase in SG&A expenses, peaking in 2023 with a staggering 105% rise from 2014. This growth reflects the company's expanding global footprint and strategic investments in marketing and administration.
Conversely, Dynavax Technologies, while smaller in scale, has seen its SG&A expenses grow by approximately 760% over the same period. This sharp increase highlights the company's aggressive push into new markets and product development.
While both companies have increased their SG&A spending, the scale and pace differ significantly, offering insights into their strategic priorities and market positioning.
Novartis AG and Dynavax Technologies Corporation: SG&A Spending Patterns Compared
Breaking Down SG&A Expenses: Pfizer Inc. vs Dynavax Technologies Corporation
Comparing SG&A Expenses: Biogen Inc. vs Dr. Reddy's Laboratories Limited Trends and Insights
Breaking Down SG&A Expenses: Insmed Incorporated vs Dynavax Technologies Corporation
Breaking Down SG&A Expenses: Dr. Reddy's Laboratories Limited vs Jazz Pharmaceuticals plc
Operational Costs Compared: SG&A Analysis of Dr. Reddy's Laboratories Limited and Taro Pharmaceutical Industries Ltd.
Who Optimizes SG&A Costs Better? Catalent, Inc. or Dynavax Technologies Corporation
Selling, General, and Administrative Costs: Ascendis Pharma A/S vs Dynavax Technologies Corporation
Selling, General, and Administrative Costs: Rhythm Pharmaceuticals, Inc. vs Dynavax Technologies Corporation
MannKind Corporation and Dynavax Technologies Corporation: SG&A Spending Patterns Compared
Cost Management Insights: SG&A Expenses for Dynavax Technologies Corporation and Galapagos NV
SG&A Efficiency Analysis: Comparing Dynavax Technologies Corporation and Novavax, Inc.